首页 | 本学科首页   官方微博 | 高级检索  
检索        

雷帕霉素抑制胆囊癌GBC-SD细胞的生长和转移
引用本文:刘兆龙,阎 波,罗芸葆,王永兵,韩策然,宋 安,俞士勇,侯 坤.雷帕霉素抑制胆囊癌GBC-SD细胞的生长和转移[J].中国肿瘤生物治疗杂志,2009,16(6):600-603.
作者姓名:刘兆龙  阎 波  罗芸葆  王永兵  韩策然  宋 安  俞士勇  侯 坤
作者单位:上海市浦东新区人民医院外科,上海,201200
摘    要:目的:研究雷帕霉素 (rapamycin) 对胆囊癌GBCSD细胞生长和转移的影响,探讨雷帕霉素治疗胆囊癌的临床应用前景。方法:采用MTT法检测不同浓度(12.5、25、50 nmol/L)的雷帕霉素对胆囊癌细胞增殖的影响,以流式细胞术检测不同浓度的雷帕霉素对细胞凋亡和细胞周期的变化,Transwell小室检测雷帕霉素对细胞迁移能力的影响,利用Western blotting检测胆囊癌细胞中雷帕霉素哺乳动物靶标(mammalian target of rapamycin,mTOR)及其磷酸化pmTOR水平。结果:雷帕霉素可显著抑制胆囊癌GBCSD细胞中mTOR的磷酸化,但对mTOR表达无影响。雷帕霉素显著抑制胆囊癌细胞的生长,并呈剂量依赖性抑制(P<0.01)。雷帕霉素可引起胆囊癌细胞周期G1/S阻滞和细胞凋亡;可显著抑制胆囊癌细胞的转移(P<001)。结论:雷帕霉素能显著抑制胆囊癌细胞生长及转移,其机制可能与抑制pmTOR通路、诱导细胞周期阻滞和细胞凋亡有关。

关 键 词:雷帕霉素    雷帕霉素哺乳动物靶标(mTOR)    胆囊肿瘤
收稿时间:2009/10/10 0:00:00
修稿时间:2009/11/18 0:00:00

Rapamycin inhibits growth and metastasis of gallbladder cancer GBC-SD cells
LIU Zhao-long,YAN Bo,LUO Yun-bao,WANG Yong-bing,HAN Ce-ran,SONG An,YU Shi-yong,and HOU Kun.Rapamycin inhibits growth and metastasis of gallbladder cancer GBC-SD cells[J].Chinese Journal of Cancer Biotherapy,2009,16(6):600-603.
Authors:LIU Zhao-long  YAN Bo  LUO Yun-bao  WANG Yong-bing  HAN Ce-ran  SONG An  YU Shi-yong  and HOU Kun
Abstract:Objective:To investigate the effect of rapamycin on cell growth and migration of gallbladder cancer GBC-SD cells, and to discuss its potential in clinical therapy of gallbladder cancer. Methods: Proliferation of GBC-SD cells treated with different concentrations of rapamycin (12.5, 25, and 50 mmol/L) was examined by MTT assay. Cell cycle distribu-tion and apoptosis of GBC-SD cells treated with different concentrations of rapamycin were determined by flow cytometry. Migration ability of GBC-SD cells was assessed by Transwell assay. The expression of mTOR (mammalian target of rapam-ycin) and its phosphorylation in GBC-SD cells were examined by Western blotting assay. Results: Rapamycin significant-ly inhibited the phosphorylation of roTOR, but had no influence on the expression of roTOR in GBC-SD cells. Rapamycin significantly inhibited the growth of GBC-SD cells in a dose-dependent manner (P < 0.01). Raparnycin induced apoptosis of GBC-SD cells and arrested them at the G_1/S phase. Furthermore, rapamycin also significantly suppressed migration of GBC-SD cells as showed by Transwell assay (P < 0.01). Conclusion: Rapamycin can remarkably inhibit the growth and migration of gallbladder cancer cells, probably by inhibition of p-roTOR pathway, induction of apoptosis and cell cycle ar-rest of gallbladder cancer cells.
Keywords:rapamycin  mammalian target of rapamycin(mTOR)  gallbladder neoplasms
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《中国肿瘤生物治疗杂志》浏览原始摘要信息
点击此处可从《中国肿瘤生物治疗杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号